Edward Kim

Active 1995–2026

313
Papers
21,989
Citations
84
h-index
193
i10-index

Citations

Citations per year for Edward Kim1988: 1 citations1995: 1 citations1996: 9 citations1997: 9 citations1998: 8 citations1999: 12 citations2000: 23 citations2001: 33 citations2002: 32 citations2003: 34 citations2004: 39 citations2005: 38 citations2006: 43 citations2007: 43 citations2008: 48 citations2009: 62 citations2010: 69 citations2011: 92 citations2012: 59 citations2013: 89 citations2014: 91 citations2015: 115 citations2016: 141 citations2017: 134 citations2018: 182 citations2019: 735 citations2020: 918 citations2021: 1,060 citations2022: 923 citations2023: 766 citations2024: 1,264 citations2025: 644 citations2026: 47 citations1989–1994: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,114 citing papers, 28.2% of this breakdownChina: 1,303 citing papers, 11.8% of this breakdownGermany: 651 citing papers, 5.9% of this breakdownUnited Kingdom: 644 citing papers, 5.8% of this breakdownItaly: 540 citing papers, 4.9% of this breakdownFrance: 403 citing papers, 3.6% of this breakdownCanada: 388 citing papers, 3.5% of this breakdownJapan: 308 citing papers, 2.8% of this breakdownNetherlands: 289 citing papers, 2.6% of this breakdownSpain: 270 citing papers, 2.4% of this breakdownAustralia: 261 citing papers, 2.4% of this breakdownIndia: 218 citing papers, 2% of this breakdown
0%28.2%Other 24.1%

Fields

  • Medicine49.7%
  • Biochemistry, Genetics and Molecular Biology20.9%
  • Computer Science11%
  • Engineering4%
  • Materials Science3.4%
  • Neuroscience2.2%
  • Other8.8%

Topics

  • Pancreatic and Hepatic Oncology Research3.2%
  • Cancer Cells and Metastasis2.8%
  • Hepatocellular Carcinoma Treatment and Prognosis2.4%
  • Cancer Genomics and Diagnostics2.1%
  • Epigenetics and DNA Methylation1.8%
  • Cancer Immunotherapy and Biomarkers1.6%
  • Other86.1%

Coauthors

All papers

Open in search
  1. Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hans Clevers, Laura D. Wood, Ralph H. Hruban, Elizabeth D. Thompson, Andrew J. Aguirre, Brian M. Wolpin, Aaron R. Sasson, Joseph Kim, Maoxin Wu, Juan Carlos Bucobo, Peter J. Allen, Divyesh V. Sejpal, William H. Nealon, J. D. Sullivan, Jordan M. Winter, Phyllis A. Gimotty, Jean L. Grem, Dominick J. DiMaio, Jonathan M. Buscaglia, Paul M. Grandgenett, Jonathan R. Brody, Michael A. Hollingsworth, Grainne M. O’Kane, Faiyaz Notta, Edward Kim, James M. Crawford, Craig Devoe, Allyson J. Ocean, Christopher L. Wolfgang, Kenneth H. Yu, Ellen Li, Christopher R. Vakoc, Benjamin Hubert, Sandra E. Fischer, Julie M. Wilson, Richard A. Moffitt, Jennifer J. Knox, Alexander Krasnitz, Steven Gallinger, David A. Tuveson - Cancer Discovery 2018 cited by 1,094

  2. Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study

    Authors: , , , , , , , , - Hepatology 2021 cited by 513

  3. Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , C. Hennequin, Hajra Jamal, Haley E. Brown, Antoinette Bonaccorso, Daniel M. Labow, Umut Sarpel, Talia D. Rosenbloom, Max W. Sung, Baijun Kou, Siyu Li, Vladimir Janković, Nicola James, Sara Hamon, Hung Kam Cheung, Jennifer S. Sims, Elizabeth Miller, Nina Bhardwaj, Gavin Thurston, Israel Lowy, Sacha Gnjatic, Bachir Taouli, Myron Schwartz, Miriam Mérad - ˜The œLancet. Gastroenterology & hepatology 2022 cited by 218

  4. Data-driven materials research enabled by natural language processing and information extraction

    Authors: , , , , , , - Applied Physics Reviews 2020 cited by 294

  5. Scenic: A Language for Scenario Specification and Data Generation

    Authors: , , , , , , - Machine Learning, Mach. Learn. 2022 cited by 84

  6. VerifAI: A Toolkit for the Formal Design and Analysis of Artificial Intelligence-Based Systems

    Authors: , , , , , , - Lecture notes in computer science, CAV (1) 2019 cited by 191

  7. Enhancer Reprogramming Promotes Pancreatic Cancer Metastasis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Cell 2017 cited by 496

  8. Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Melissa N. Zimel, Lisa E. Hang, Hema Sundar, Mary Anne Bergman - Journal of the National Comprehensive Cancer Network 2022 cited by 1,157

  9. Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002–2020)

    Authors: , , , , , , , , , , - Gastroenterology 2021 cited by 244

  10. Systematic literature review of schizophrenia clinical practice guidelines on acute and maintenance management with antipsychotics

    Authors: , , , , , , , , - Schizophrenia 2022 cited by 149

  11. Radiation segmentectomy for curative intent of unresectable very early to early stage hepatocellular carcinoma (RASER): a single-centre, single-arm study

    Authors: , , , , , , , , , , , , - ˜The œLancet. Gastroenterology & hepatology 2022 cited by 147

  12. Materials Synthesis Insights from Scientific Literature via Text Extraction and Machine Learning

    Authors: , , , , , - Chemistry of Materials 2017 cited by 475

  13. Open-label, Phase I Study of Nivolumab Combined with nab -Paclitaxel Plus Gemcitabine in Advanced Pancreatic Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2020 cited by 154

  14. Sotorasib with panitumumab in chemotherapy-refractory KRASG12C-mutated colorectal cancer: a phase 1b trial

    Authors: , , , , , , , , , , , , , , , , , , - Nature Medicine 2024 cited by 89

  15. Elo Uncovered: Robustness and Best Practices in Language Model Evaluation

    Authors: , , , , - Advances in Neural Information Processing Systems 37, NeurIPS 2024 cited by 86

  16. Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group

    Authors: , , , , , , , , , , , , , - European Journal of Nuclear Medicine and Molecular Imaging 2022 cited by 104

  17. The contemporary spectrum of multiple sclerosis misdiagnosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Neurology 2016 cited by 324

  18. Snow depth variability in the Northern Hemisphere mountains observed from space

    Authors: , , , , , , , , , , , , , , , , - Nature Communications 2019 cited by 458

  19. Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview

    Authors: , , , , , , , - CNS Drugs 2021 cited by 189

  20. Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study

    Authors: , , , , , , , , , , , , , , , , , , , , - ˜The œLancet. Gastroenterology & hepatology 2020 cited by 246

  21. Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma

    Authors: , , , , , , , , , , , - Clinical Cancer Research 2014 cited by 306

  22. A Machine Learning Approach to Zeolite Synthesis Enabled by Automatic Literature Data Extraction

    Authors: , , , , , , , - ACS Central Science 2019 cited by 283

  23. Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John W. R. Schwabe, Andrea Mattevi, Rhoda M. Alani, Philip A. Cole - Nature Communications 2018 cited by 233

  24. Correlation of Y90-absorbed radiation dose to pathological necrosis in hepatocellular carcinoma: confirmatory multicenter analysis in 45 explants

    Authors: , , , , , , - European Journal of Nuclear Medicine and Molecular Imaging 2020 cited by 155